1. Centers for Disease Control and Prevention. Ten great public health achievements—United States, 2001-2010. MMWR. 2011;60(19):619-623. Data from Zhou F. Updated economic evaluation of the routine childhood immunization schedule in the United States. Presented at: 45th National Immunization Conference; March 28-31, 2011; Washington, DC. [PDF]
  2. Johnson D, Nichol KL, Lipczynski K. Barriers to adult immunization. Am J Med. 2008; 121: S28 -S35. [PDF]
  3. US Department of Health and Human Services, Centers for Disease Control and Prevention. Immunization Works newsletters. Page last modified on June 3, 2011. [Link]
  4. Yarnall KS, Pollak KI, Østbye T, Krause KM, Michener JL. Primary care: is there enough time for prevention? Am J Publ Health. 2003;93(4):635-641. [PDF]
  5. US Department of Health and Human Services, Centers for Disease Control and Prevention. Materials: provider resources for vaccine conversations with parents. Page last modified on June 15, 2011. [Link]
  6. McKibben LJ, Stange PV, Sneller VP, Strikas RA, Rodewald LE, Briss PA, Advisory Committee on Immunization Practices. Use of standing orders programs to increase adult vaccination rates MMWR Recomm Rep. 2000;49(RR-1):15-26. [Full Text]
  7. Task Force on Community Preventive Services. Recommendations regarding interventions to improve vaccination coverage in children, adolescents, and adults. Am J Prev Med. 2000;18(1 suppl):92-96.
  8. Willis BC, Ndiaye SM, Hopkins DP, Shefer A, Task Force on Community Preventive Services. Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged <65 years at high risk. A report on recommendations of the Task Force on Community Preventive Services. MMWR Recomm Rep. 2005;54(RR-5):1-11. [Full Text]
  9. Kennedy A, LaVail K, Nowak G, et al. Confidence about vaccines in the United States: understanding parents’ perceptions. Health Aff. 2011;30(6):1151-1159. [Abstract]
  10. Centers for Disease Control and Prevention. Healthy People 2020 Summary of Objectives. Page last accessed on June 21, 2011. [PDF]
  11. US Department of Health and Human Services, Centers for Disease Control and Prevention. Vaccine information statement (interim) human papillomavirus (HPV) Cervarix. May 3, 2011. [PDF]
  12. Centers for Disease Control and Prevention. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR. 2010;59(20):630-632. [PDF]
  13. Centers for Disease Control and Prevention. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR. 2010;59(20):626-629. [PDF]
  14. Centers for Disease Control and Prevention. Updated recommendations from the Advisory Committee on Immunization Practices (ACIP) for use of hepatitis A vaccine in close contacts of newly arriving international adoptees. MMWR. 2009;58(36):1006-1007. [Link]
  15. Centers for Disease Control and Prevention. Update: prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2007;56(41):1080-1084. [Link]
  16. Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices, 2010. MMWR Recomm Rep. 2010;59(RR-8):1-62. [PDF]
  17. Hibberd PL. Approach to immunizations in healthy adults. UpToDate. 19.1. Last literature review version 19.1: January 2011. Page last modified on February 4, 2011. [Abstract]
  18. Centers for Disease Control and Prevention. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR. 2010;59(34):1102-1106. [PDF]
  19. Centers for Disease Control and Prevention. Pertussis (whooping cough). Page last modified on March 15, 2011. [Link]
  20. McQuillan GM, Kruszon-Moran D, Deforest A, Chu SY, Wharton M. Serologic immunity to diphtheria and tetanus in the United States. Ann Intern Med. 2002;136(9):660-666. [PDF]
  21. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR. 2011;60(1):13-15. [PDF]
  22. Centers for Disease Control and Prevention. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep. 2006;55(RR-17):1-33. [Link]
  23. Centers for Disease Control and Prevention. Tetanus surveillance—United States, 2001-2008. MMWR. 2011;60(12):365-369. [PDF]
  24. Centers for Disease Control and Prevention. Prevention of herpes zoster. Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2008;57(RR-5):1-30. [Link]
  25. Hurley LP, Lindley MC, Harpaz R, et al. Barriers to the use of herpes zoster vaccine. Ann Intern Med. 2010;152(9):555-560. [PDF]
  26. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271-2284. [PDF]
  27. Centers for Disease Control and Prevention. Catch-up immunization schedule for persons aged 4 months through 18 years who start late or who are more than 1 month behind—United States, 2011. Page last accessed on June 22, 2011. [PDF]
  28. Centers for Disease Control and Prevention. Updated recommendations for use of meningococcal conjugate vaccines—Advisory Committee on Immunization Practices (ACIP), 2010. MMWR. 2011;60(3):72-76. [Link]
  29. Centers for Disease Control and Prevention. CDC survey finds childhood immunization rates remain high [press release]. September 16, 2010. [Link]
  30. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998;351(9103):637-641. [PDF]
  31. Gerber JS, Offit PA. Vaccines and autism: a tale of shifting hypotheses. Clin Infect Dis. 2009;48(4):456-461. [PDF]
  32. Centers for Disease Control and Prevention. Frequently asked questions about multiple vaccinations and the immune system. Page last modified on February 21, 2011. [Link]
  33. Offit PA, Moser CA. The problem with Dr. Bob’s alternative vaccine schedule. Pediatrics. 2009; 123:e164-e169. [PDF]
  34. Healthcare.gov. Affordable Care Act and immunizations [fact sheet]. September 14, 2010. [Link]
  35. Editors of The Lancet. Retraction—Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children]. Lancet. 2010; 375(9713):445. [PDF]
  36. Centers for Disease Control and Prevention. Rotavirus vaccine (RotaShield®) and intussusception. Historical information as RotaShield® was taken off US market in 1999. Page last modified on June 23, 2010. [Link]
  37. Centers for Disease Control and Prevention. Vaccines and preventable diseases: rotavirus vaccination. Page last modified on December 6, 2010. [Link]
  38. Centers for Disease Control and Prevention. Vaccines and preventable diseases: Rotarix® rotavirus vaccine: rare side effect possible. Page last modified on September 30, 2010. [Link]

 

Copyright © 2010-2013  Perelman School of Medicine at the University of Pennsylvania Office of Continuing Medical Education. All rights reserved.